drugset / Trial / NCT07000760

Intraoperative Nebulization of Lidocaine and Postoperative Pulmonary Complications

NCT07000760

Phase 3 Completed 270 enrolled Jun Zhang
RandomizedParallel-groupTriple-blindPrevention

Summary

There is high incidence of postoperative pulmonary complications (PPCs) in patients undergoing major abdominal surgeries.PPCs significantly prolongs the hospital stay of patients, increases their economic burden, and raises the mortality rates within 30 days and 1 year after surgery. The inflammatory response during the perioperative period plays an important role in the occurrence and development of PPCs. The anti-inflammatory effect of lidocaine has a potential lung protection mechanism. The purpose of this study is to explore the effect of nebulization of lidocaine on the incidence of PPCs. The investigators hypothesized that intraoperative nebulization of lidocaine could reduce the incidence of PPCs.

Timeline

Start
2025-06-06
Primary completion
2026-01-23
Completion
2026-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 100 mg Inhaled

Indications

No indication recorded.